Skip to main content
Theralase Technologies Inc. (TLTFF)
OTCMKTS · Delayed Price · Currency is USD
0.1400
+0.0015 (1.11%)
Apr 24, 2025, 4:00 PM EDT

Theralase Technologies Revenue

In the year 2024, Theralase Technologies had annual revenue of 1.03M CAD, down -3.45%. Theralase Technologies had revenue of 410.45K in the quarter ending December 31, 2024, with 12.88% growth.

Revenue
1.03M CAD
Revenue Growth
-3.45%
P/S Ratio
47.50
Revenue / Employee
51.67K CAD
Employees
20
Market Cap
34.11M USD

Revenue Chart

* This company reports financials in CAD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20241.03M-36.88K-3.45%
Dec 31, 20231.07M-68.26K-6.00%
Dec 31, 20221.14M357.93K45.85%
Dec 31, 2021780.64K-148.48K-15.98%
Dec 31, 2020929.12K-34.93K-3.62%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.76B
Veradigm 588.02M
Glass House Brands 200.90M
Elite Pharmaceuticals 70.00M
Northwest Biotherapeutics 1.38M
BioStem Technologies 301.83M
American Oncology Network 1.76B
Silence Therapeutics 43.26M
Revenue Rankings

Theralase Technologies News

More News